Results 121 to 130 of about 3,535 (191)

Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence. [PDF]

Neurourol Urodyn
Almadfaa RO, Wigle PR, Lin AC, Hardee A, Guo JJ, Hincapie AL.   +5 more
europepmc   +1 more source

Mirabegron administration for the prevention of ureteral injuries during ureteral access sheath insertion. [PDF]

World J Urol
Ermiş O, Sabuncu K, Kaçtan Ç, Karakuş B, Sürmeli B, Boz MY, Horuz R.   +6 more
europepmc   +1 more source

Sex-dependent activation of apamin-sensitive small-conductance Ca²⁺-activated K⁺ current by β1-adrenergic stimulation in rabbit ventricles. [PDF]

J Physiol
Yang M, Zhang L, Kote A, Fisher C, Tisdale JE, Chen Z, Everett TH, Liu X, Chen PS.   +8 more
europepmc   +1 more source

Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses. [PDF]

Front Pharmacol
Nagura K, Watanabe S, Watanabe T, Sagara H.   +3 more
europepmc   +1 more source

Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products. [PDF]

Sci Rep
Kamel EB, Badrawy M, Nour IM.
europepmc   +1 more source

Diagnostic et prise en charge de l’incontinence urinaire féminine. [PDF]

CMAJ
Gagnon LH, Edell H, Lee PE.
europepmc   +1 more source

An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]

Medicine (Baltimore)
Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc   +1 more source

Editorial Comment on: Use and Persistence of Beta-3 Adrenoceptor Agonists for the Treatment of Overactive Bladder. [PDF]

Int J Urol
Mochizuki T.
europepmc   +1 more source

Serial patent litigation: an emerging strategy to delay entry of generic competition. [PDF]

Health Aff Sch
Bonis T, Kesselheim AS, Tu S.
europepmc   +1 more source

Navigating the challenges of overactive bladder management in women. [PDF]

World J Urol
Braga A, Goldman HB, Padoa A, Serati M.
europepmc   +1 more source